REGISTERED
on 23 Jul 2024
Last Applicant/ Owned by
GSK Medicines Research Centre
Stevenage
GB
SG12NY
Serial Number
98269999 filed on 14th Nov 2023
Registration Number
7458189 registered on 23rd Jul 2024
Correspondent Address
Christopher M. Hanes
Filing Basis
No Filing Basis
Disclaimer
NO DATA
KOTIMREE
Vaccines; Anti-infectives; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepat Read More
Classification Information
Class [005]
Pharmaceutical Products
Vaccines; Anti-infectives; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 98269999
Mark Type
No Service/Collective Mark
Attorney Docket Number
No 84263533
44D Filed
Yes
44D Current
No
44E filed
Yes
44E Current
Yes
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 23rd Jul 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 23rd Jul 2024 | REGISTERED-PRINCIPAL REGISTER |
| 07th May 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 07th May 2024 | PUBLISHED FOR OPPOSITION |
| 17th Apr 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 01st Apr 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 26th Mar 2024 | ASSIGNED TO EXAMINER |
| 01st Feb 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| 14th Nov 2023 | NEW APPLICATION ENTERED |